Image Credit: STAT News
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and eye disease, European pharma reforms, and more
HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments